| Stage | GRC | % of rev | IRM | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $193M | 100.00% | $2.0B | 100.00% | IRM ×10.30 |
| Gross profit | $65M | 33.39% | $1.1B | 53.45% | IRM +20.1pp |
| Operating income | $34M | 17.54% | $411M | 20.63% | IRM +3.1pp |
| Pre-tax income | $30M | 15.44% | $186M | 9.32% | GRC +6.1pp |
| Net income | $23M | 11.75% | $129M | 6.47% | GRC +5.3pp |
| Stage | GRC | IRM | Gap · A − B |
|---|---|---|---|
| Revenue | $193M100.00% | $2.0B100.00% | IRM ×10.30 |
| Gross profit | 33.39%$65M | 53.45%$1.1B | IRM +20.1pp |
| Operating income | 17.54%$34M | 20.63%$411M | IRM +3.1pp |
| Pre-tax income | 15.44%$30M | 9.32%$186M | GRC +6.1pp |
| Net income |
| 11.75%$23M |
| 6.47%$129M |
| GRC +5.3pp |
None
No disclosed counterparties: GRC.